CE15 - Immunologie, Infectiologie et Inflammation 2021

Inhibition of flavivirus replication by a chromatin-remodeling factor – ViroChrom

Submission summary

The interferon response protects cells from invading viruses by inducing the expression of around 2,000 interferon-stimulated genes (ISGs). Only a handful of these ISGs have been well characterized. Using a loss-of-function strategy, we screened an original library of 1156 siRNAs targeting around 386 individual curated human ISGs (46% new). We have identified MTA2, a chromatin-remodeling factor, as a novel ISG that potently inhibits the replication of Zika virus, an emerging RNA virus belonging to the flavivirus genus. We propose to perform an in-depth characterization of the mode of action of MTA2 by using an innovative combination of virological and chromatin assays. Our work will increase our fundamental knowledge of antiviral response against members of the flavivirus genus. Furthermore, taking advantage of naturally occurring viral inhibitors, such as MTA2, may be an effective strategy for the development of novel drugs that activate, amplify or mimic their action.

Project coordination

Nolwenn Jouvenet (Unité de Signalisation Antivirale)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partnership

Unité de Signalisation Antivirale
IC Institut Curie

Help of the ANR 365,688 euros
Beginning and duration of the scientific project: December 2021 - 42 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter